Sylvain Lehmann
#161,752
Most Influential Person Now
Researcher
Sylvain Lehmann's AcademicInfluence.com Rankings
Sylvain Lehmanncomputer-science Degrees
Computer Science
#9367
World Rank
#9840
Historical Rank
Data Mining
#225
World Rank
#226
Historical Rank
Algorithms
#379
World Rank
#384
Historical Rank
Computational Linguistics
#2249
World Rank
#2272
Historical Rank
Download Badge
Computer Science
Sylvain Lehmann's Degrees
- PhD Computer Science Université Paris Cité
- Bachelors Mathematics University of Bordeaux
Similar Degrees You Can Earn
Why Is Sylvain Lehmann Influential?
(Suggest an Edit or Addition)Sylvain Lehmann's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Signal transduction through prion protein. (2000) (795)
- Sulfated Glycans Stimulate Endocytosis of the Cellular Isoform of the Prion Protein, PrPC, in Cultured Cells (*) (1995) (675)
- Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. (2011) (436)
- Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. (2008) (326)
- Screening of 145 Anti-PrP Monoclonal Antibodies for Their Capacity to Inhibit PrPSc Replication in Infected Cells* (2005) (311)
- Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update. (2012) (291)
- Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study (2015) (255)
- A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease (2020) (252)
- Successful Transmission of Three Mouse-Adapted Scrapie Strains to Murine Neuroblastoma Cell Lines Overexpressing Wild-Type Mouse Prion Protein (2000) (243)
- Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein (2001) (225)
- Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease (2019) (212)
- Prion infection impairs the cellular response to oxidative stress. (2000) (210)
- Prion protein as trans-interacting partner for neurons is involved in neurite outgrowth and neuronal survival (2003) (195)
- Expression of Prion Protein Increases Cellular Copper Binding and Antioxidant Enzyme Activities but Not Copper Delivery* (2003) (183)
- Oxidative stress and the prion protein in transmissible spongiform encephalopathies (2002) (180)
- Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper (2008) (178)
- Blockade of Glycosylation Promotes Acquistion of Scrapie-like Properties by the Prion Protein in Cultured Cells* (1997) (177)
- Cationic phosphorus-containing dendrimers reduce prion replication both in cell culture and in mice infected with scrapie. (2004) (168)
- Alpha‐ and beta‐ cleavages of the amino‐terminus of the cellular prion protein (2004) (166)
- Evidence for a Six-transmembrane Domain Structure of Presenilin 1* (1997) (161)
- A Mutant Prion Protein Displays an Aberrant Membrane Association When Expressed in Cultured Cells (*) (1995) (161)
- Standard Preanalytical Coding for Biospecimens: Defining the Sample PREanalytical Code (2010) (160)
- Cleavage of the Amino Terminus of the Prion Protein by Reactive Oxygen Species* (2001) (153)
- Epidemiological and experimental studies on a new incident of transmissible mink encephalopathy. (1991) (153)
- Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis (2007) (146)
- Filipin Prevents Pathological Prion Protein Accumulation by Reducing Endocytosis and Inducing Cellular PrP Release* (2002) (146)
- Mutant and Infectious Prion Proteins Display Common Biochemical Properties in Cultured Cells (*) (1996) (144)
- Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles (2008) (141)
- Retrovirus infection strongly enhances scrapie infectivity release in cell culture (2006) (128)
- Amphotericin B Inhibits the Generation of the Scrapie Isoform of the Prion Protein in Infected Cultures (2000) (123)
- Anti‐PrP antibodies block PrPSc replication in prion‐infected cell cultures by accelerating PrPC degradation (2004) (120)
- Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis (2015) (119)
- Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study (2018) (117)
- [The prion protein]. (2002) (116)
- Phorbol Ester-regulated Cleavage of Normal Prion Protein in HEK293 Human Cells and Murine Neurons* (2000) (114)
- Stimulation of PrPC Retrograde Transport toward the Endoplasmic Reticulum Increases Accumulation of PrPSc in Prion-infected Cells* (2002) (113)
- Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study (2020) (110)
- Current and future use of “dried blood spot” analyses in clinical chemistry (2013) (109)
- Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification (2020) (108)
- Human Biospecimen Research: Experimental Protocol and Quality Control Tools (2009) (103)
- Depletion of one, six, twelve or twenty major blood proteins before proteomic analysis: the more the better? (2009) (102)
- Metal ions and prion diseases. (2002) (101)
- Risk of Alzheimer's disease biological misdiagnosis linked to cerebrospinal collection tubes. (2012) (97)
- Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers (2018) (96)
- Identification of Intermediate Steps in the Conversion of a Mutant Prion Protein to a Scrapie-like Form in Cultured Cells* (1997) (96)
- Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study (2015) (95)
- Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies. (2016) (95)
- Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform. (1996) (93)
- Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers (2008) (91)
- Prion propagation in cultured cells. (2003) (91)
- PrP‐dependent cell adhesion in N2a neuroblastoma cells (2002) (90)
- PrP Expression and Replication by Schwann Cells: Implications in Prion Spreading (2002) (90)
- Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity. (2016) (88)
- Comparative proteomic analysis of human mesenchymal and embryonic stem cells: Towards the definition of a mesenchymal stem cell proteomic signature (2009) (85)
- The Human “Prion-like” Protein Doppel Is Expressed in Both Sertoli Cells and Spermatozoa* (2002) (83)
- Scrapie-like prion protein is translocated to the nuclei of infected cells independently of proteasome inhibition and interacts with chromatin (2004) (80)
- Trehalose impairs aggregation of PrPSc molecules and protects prion-infected cells against oxidative damage. (2008) (79)
- Operational definition of Active and Healthy Ageing (AHA): A conceptual framework (2015) (77)
- Protein biochip systems for the clinical laboratory (2005) (77)
- Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study (2019) (72)
- Cerebrospinal fluid levels of orexin-A and histamine, and sleep profile within the Alzheimer process (2017) (71)
- Correlations between soluble α/β forms of amyloid precursor protein and Aβ38, 40, and 42 in human cerebrospinal fluid (2010) (70)
- Intersite variability of CSF Alzheimer’s disease biomarkers in clinical setting (2013) (69)
- Brain and buffy coat transmission of bovine spongiform encephalopathy to the primate Microcebus murinus (2002) (68)
- Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria (2012) (67)
- Neuropathology of iatrogenic Creutzfeldt–Jakob disease and immunoassay of French cadaver-sourced growth hormone batches suggest possible transmission of tauopathy and long incubation periods for the transmission of Abeta pathology (2018) (66)
- The scrapie prion protein is present in flotillin‐1‐positive vesicles in central‐ but not peripheral‐derived neuronal cell lines (2005) (65)
- Impact of harmonization of collection tubes on Alzheimer's disease diagnosis (2014) (64)
- Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies. (2014) (64)
- Prion Infection Impairs Copper Binding of Cultured Cells* (2003) (63)
- Cell biology of the prion protein. (1996) (61)
- X-linked adrenal hypoplasia congenita is caused by abnormal nuclear localization of the DAX-1 protein (2002) (58)
- Cerebrospinal fluid collection tubes: a critical issue for Alzheimer disease diagnosis. (2012) (56)
- Decreased sAβPPβ, Aβ38, and Aβ40 cerebrospinal fluid levels in frontotemporal dementia. (2011) (55)
- Impact of the 2008-2012 French Alzheimer Plan on the use of cerebrospinal fluid biomarkers in research memory center: the PLM Study. (2013) (53)
- Comparative analysis of protein expression of three stem cell populations: models of cytokine delivery system in vivo. (2013) (53)
- An endogenous lectin and one of its neuronal glycoprotein ligands are involved in contact guidance of neuron migration. (1990) (52)
- Quantitative Clinical Chemistry Proteomics (qCCP) using mass spectrometry: general characteristics and application (2013) (52)
- Structure-function analysis reveals the molecular determinants of the impaired biological function of DAX-1 mutants in AHC patients. (2003) (49)
- Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations (2004) (48)
- Prion strains are differentially released through the exosomal pathway (2015) (48)
- Developmental determinants in non-communicable chronic diseases and ageing (2015) (48)
- Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLMR Scale (2018) (47)
- A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles (2014) (46)
- Alzheimer's Disease: Advances in Drug Development. (2018) (45)
- Hypocretin and brain β-amyloid peptide interactions in cognitive disorders and narcolepsy (2014) (45)
- New hospital disinfection processes for both conventional and prion infectious agents compatible with thermosensitive medical equipment. (2009) (43)
- Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders (2020) (43)
- Prion protein suppresses perturbation of cellular copper homeostasis under oxidative conditions. (2004) (43)
- Central Nervous System and Peripheral Inflammatory Processes in Alzheimer’s Disease: Biomarker Profiling Approach (2015) (43)
- Efficient inhibition of infectious prions multiplication and release by targeting the exosomal pathway (2015) (42)
- Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis (2020) (42)
- Neural Stem Cell Model for Prion Propagation (2006) (42)
- Prion protein protects against DNA damage induced by paraquat in cultured cells. (2004) (42)
- Cyclodextrins Inhibit Replication of Scrapie Prion Protein in Cell Culture (2007) (41)
- Biological and Biochemical Characteristics of Prion Strains Conserved in Persistently Infected Cell Cultures (2005) (39)
- Effect of Congo Red on Wild‐Type and Mutated Prion Proteins in Cultured Cells (2000) (38)
- White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation (2018) (38)
- Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity (2020) (36)
- From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid (2016) (36)
- Tubulin Beta-3 Chain as a New Candidate Protein Biomarker of Human Skin Aging: A Preliminary Study (2017) (36)
- Techniques in Prion Research (2004) (34)
- The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases (2015) (34)
- Interest of major serum protein removal for Surface-Enhanced Laser Desorption/Ionization – Time Of Flight (SELDI-TOF) proteomic blood profiling (2006) (33)
- MACVIA-LR, Reference site of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) in Languedoc Roussillon (2014) (33)
- Location of a transiently expressed glycoprotein in developing cerebellum delineating its possible ontogenetic roles (1989) (33)
- SILK studies — capturing the turnover of proteins linked to neurodegenerative diseases (2019) (32)
- Antibody-free quantification of seven tau peptides in human CSF using targeted mass spectrometry (2015) (32)
- Quantitative proteomic approach to understand metabolic adaptation in non-small cell lung cancer. (2014) (31)
- Prion Replication Occurs in Endogenous Adult Neural Stem Cells and Alters Their Neuronal Fate: Involvement of Endogenous Neural Stem Cells in Prion Diseases (2013) (30)
- [Cell culture models of transmissible spongiform encephalopathies]. (2001) (29)
- Recombinant Human Prion Protein Inhibits Prion Propagation in vitro (2013) (29)
- The truncated 23-230 form of the prion protein localizes to the nuclei of inducible cell lines independently of its nuclear localization signals and is not cytotoxic (2006) (28)
- Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer’s disease at the prodromal stage (2018) (28)
- A novel copper-hydrogen peroxide formulation for prion decontamination. (2006) (28)
- Cellular pathogenesis in prion diseases. (2008) (28)
- Quantitative detection of amyloid-β peptides by mass spectrometry: state of the art and clinical applications (2015) (27)
- Clinical mass spectrometry proteomics (cMSP) for medical laboratory: What does the future hold? (2017) (27)
- Performance evaluation of human cytokines profiles obtained by various multiplexed-based technologies underlines a need for standardization (2013) (27)
- Prion‐like protein Doppel expression is not modified in scrapie‐infected cells and in the brains of patients with Creutzfeldt–Jakob disease (2003) (26)
- Peripheral Blood and Salivary Biomarkers of Blood–Brain Barrier Permeability and Neuronal Damage: Clinical and Applied Concepts (2021) (26)
- Stem cell therapy extends incubation and survival time in prion-infected mice in a time window-dependant manner. (2011) (25)
- Antibodies to cerebellar soluble lectin CSL in multiple sclerosis (1990) (25)
- Glycoproteins and lectins in cell adhesion and cell recognition processes (1992) (25)
- Prions Impair Bioaminergic Functions through Serotonin- or Catecholamine-derived Neurotoxins in Neuronal Cells* (2008) (25)
- Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker–based case–control study (2020) (25)
- Human S100A10 plays a crucial role in the acquisition of the endometrial receptivity phenotype (2016) (24)
- Absolute quantification of 35 plasma biomarkers in human saliva using targeted MS. (2016) (24)
- Diagnosis of Methionine/Valine Variant Creutzfeldt-Jakob Disease by Protein Misfolding Cyclic Amplification (2018) (24)
- Association between serum hepcidin level and restless legs syndrome (2018) (24)
- Rapid and Highly Sensitive Detection of Variant Creutzfeldt - Jakob Disease Abnormal Prion Protein on Steel Surfaces by Protein Misfolding Cyclic Amplification: Application to Prion Decontamination Studies (2016) (23)
- Artifactual Sulfation of Silver-stained Proteins (2009) (23)
- Trafficking of the cellular isoform of the prion protein. (1999) (23)
- Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation. (2016) (23)
- Effect of Amphotericin B on Wild‐Type and Mutated Prion Proteins in Cultured Cells (2000) (22)
- Proteomics of primary mesenchymal stem cells. (2006) (22)
- Biomarkers of Alzheimer's disease: the present and the future. (2013) (21)
- Lesion-induced re-expression of neonatal recognition molecules in adult rat cerebellum (1993) (21)
- Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals (2020) (20)
- Clinical measurement of Hepcidin-25 in human serum: Is quantitative mass spectrometry up to the job? (2014) (20)
- Cerebrospinal fluid chitinase-3-like protein 1 level is not an independent predictive factor for the risk of clinical conversion in radiologically isolated syndrome (2019) (19)
- The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases (2019) (19)
- Impurity determination for hepcidin by liquid chromatography-high resolution and ion mobility mass spectrometry for the value assignment of candidate primary calibrators (2017) (19)
- [Preanalytical guidelines for clinical proteomics investigation of biological fluids]. (2009) (19)
- Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics. (2016) (19)
- Isolation of Exosomes and Microvesicles from Cell Culture Systems to Study Prion Transmission. (2017) (18)
- Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer’s disease in adults with Down syndrome (2021) (18)
- Crumpling of silver nanowires by endolysosomes strongly reduces toxicity (2019) (18)
- Systemic Delivery of siRNA Down Regulates Brain Prion Protein and Ameliorates Neuropathology in Prion Disorder (2014) (18)
- Development of new quantitative mass spectrometry and semi-automatic isofocusing methods for the determination of Apolipoprotein E typing. (2016) (18)
- N‐homocysteinylation of tau and MAP1 is increased in autopsy specimens of Alzheimer's disease and vascular dementia (2019) (18)
- Impact of treating iron deficiency, diagnosed according to hepcidin quantification, on outcomes after a prolonged ICU stay compared to standard care: a multicenter, randomized, single-blinded trial (2020) (17)
- Oligomeric-Induced Activity by Thienyl Pyrimidine Compounds Traps Prion Infectivity (2011) (17)
- Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome (2021) (17)
- Detection of amyloid beta peptides in body fluids for the diagnosis of alzheimer’s disease: Where do we stand? (2019) (17)
- Proteomic consequences of expression and pathological conversion of the prion protein in inducible neuroblastoma N2a cells (2010) (17)
- BSE infection of the small short-lived primate Microcebus murinus. (2002) (17)
- Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias (2021) (17)
- Operative definition of active and healthy ageing (AHA): Meeting report. Montpellier October 20-21, 2014 (2015) (17)
- Impact of treating iron deficiency, diagnosed according to hepcidin quantification, on outcomes after a prolonged ICU stay compared to standard care: a multicenter, randomized, single-blinded trial (2020) (17)
- A new genetic algorithm in proteomics: Feature selection for SELDI-TOF data (2008) (16)
- Tau hyperphosphorylation on T217 in cerebrospinal fluid is specifically associated to amyloid-β pathology (2017) (16)
- Clinical perspectives of dried blood spot protein quantification using mass spectrometry methods (2017) (16)
- Hepcidin and ferritin levels in restless legs syndrome: a case–control study (2020) (16)
- Nanoparticles in foods? A multiscale physiopathological investigation of iron oxide nanoparticle effects on rats after an acute oral exposure: Trace element biodistribution and cognitive capacities. (2019) (15)
- Exacerbated CSF abnormalities in younger patients with Alzheimer's disease (2013) (15)
- Diagnosis associated with Tau higher than 1200 pg/mL: Insights from the clinical and laboratory practice. (2019) (15)
- Reduced brain amyloid burden in elderly patients with narcolepsy type 1 (2018) (15)
- Correlation between Bioassay and Protein Misfolding Cyclic Amplification for Variant Creutzfeldt-Jakob Disease Decontamination Studies (2020) (14)
- Presence of anti-CSL antibodies in the cerebrospinal fluid of patients: A sensitive and specific test in the diagnosis of multiple sclerosis (1994) (14)
- Towards a routine application of Top-Down approaches for label-free discovery workflows. (2017) (14)
- A Clinico-Radiological Study of Cerebral Amyloid Angiopathy-Related Inflammation (2019) (14)
- Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Isolated Supratentorial Cortical Superficial Siderosis. (2016) (14)
- Intranasal instillation of iron oxide nanoparticles induces inflammation and perturbation of trace elements and neurotransmitters, but not behavioral impairment in rats (2018) (13)
- Sample Pooling and Inflammation Linked to the False Selection of Biomarkers for Neurodegenerative Diseases in Top–Down Proteomics: A Pilot Study (2018) (13)
- Cerebral Amyloid Angiopathy and Cerebral Amyloid Angiopathy-Related Inflammation: Comparison of Hemorrhagic and DWI MRI Features. (2018) (13)
- Development and validation of dried matrix spot sampling for the quantitative determination of amyloid β peptides in cerebrospinal fluid (2014) (13)
- The importance of an integrated genotype-phenotype strategy to unravel the molecular bases of titinopathies (2020) (13)
- Impact of CSF storage volume on the analysis of Alzheimer's disease biomarkers on an automated platform. (2019) (13)
- In Vitro Dermal Safety Assessment of Silver Nanowires after Acute Exposure: Tissue vs. Cell Models (2018) (13)
- A wild-type prion protein does not acquire properties of the scrapie isoform when coexpressed with a mutant prion protein in cultured cells. (1997) (12)
- Late-onset behavioral variant of frontotemporal lobar degeneration versus Alzheimer's disease: Interest of cerebrospinal fluid biomarker ratios (2015) (12)
- Quantification of hepcidin-25 in human cerebrospinal fluid using LC-MS/MS. (2017) (12)
- Cerebrospinal fluid anti-cerebellar soluble lectin antibodies in human immunodeficiency virus type 1 infection (1992) (12)
- Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview (2021) (12)
- Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation. (2018) (11)
- Comparison of HbA1c detection in whole blood and dried blood spots using an automated ion-exchange HPLC system. (2017) (11)
- Differential expression of an endogenous mannose-binding protein R1 during muscle development and regeneration delineating its role in myoblast fusion. (1994) (11)
- Mutations modifying sporadic Alzheimer's disease age of onset (2016) (11)
- Initial memory deficit profiles in patients with a cerebrospinal fluid Alzheimer's disease signature. (2014) (11)
- Genetic heterogeneity versus molecular analysis of prion susceptibility in neuroblasma N2a sublines (2008) (11)
- The Role of the Prion Protein in the Molecular Basis for Synaptic Plasticity and Nervous System Development (2007) (11)
- Production of a monoclonal antibody, against human α-synuclein, in a subpopulation of C57BL/6J mice, presenting a deletion of the α-synuclein locus (2010) (11)
- An endogenous lectin and its glycoprotein ligands are triggering basal and axon-induced Schwann cell proliferation. (1995) (11)
- Prion propagation in cell culture. (2005) (11)
- Gene and cell therapy for prion diseases. (2009) (11)
- Effects of Iron Oxide Nanoparticles (γ-Fe2O3) on Liver, Lung and Brain Proteomes following Sub-Acute Intranasal Exposure: A New Toxicological Assessment in Rat Model Using iTRAQ-Based Quantitative Proteomics (2019) (10)
- Multicenter Analytical Validation of Aβ40 Immunoassays (2017) (10)
- Deconstructing Alzheimer’s Disease: How to Bridge the Gap between Experimental Models and the Human Pathology? (2021) (10)
- Can we rely only on ratios of cerebrospinal fluid biomarkers for AD biological diagnosis? (2015) (10)
- Data from a targeted proteomics approach to discover biomarkers in saliva for the clinical diagnosis of periodontitis (2018) (10)
- Stable Isotope Labeling by Amino acid in Vivo (SILAV): a new method to explore protein metabolism. (2015) (10)
- What sample preparation should be chosen for targeted MS monoclonal antibody quantification in human serum? (2018) (10)
- Impact of iron deficiency diagnosis using hepcidin mass spectrometry dosage methods on hospital stay and costs after a prolonged ICU stay: Study protocol for a multicentre, randomised, single-blinded medico-economic trial. (2017) (10)
- Assessing a multiplex-targeted proteomics approach for the clinical diagnosis of periodontitis using saliva samples. (2018) (10)
- Cytokines as new biomarkers of skin wound vitality (2021) (10)
- Autoantibody profiling on high-density protein microarrays for biomarker discovery in the cerebrospinal fluid. (2008) (10)
- A large scale proteome analysis of the gefitinib primary resistance overcome by KDAC inhibition in KRAS mutated adenocarcinoma cells overexpressing amphiregulin. (2019) (9)
- Investigating the toxic effects induced by iron oxide nanoparticles on neuroblastoma cell line: an integrative study combining cytotoxic, genotoxic and proteomic tools (2019) (9)
- Prion diseases and adult neurogenesis: How do prions counteract the brain's endogenous repair machinery? (2014) (9)
- Endogenous Lectin Cerebellar Soluble Lectin Involved in Myelination Is Absent from Nonmyelinating Schwann Cells (1992) (9)
- Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview (2021) (9)
- Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease (2018) (9)
- Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR study (2022) (9)
- The Aβ1–42/Aβ1–40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1–42 alone (2022) (8)
- Lithium as a disease-modifying agent for prion diseases (2018) (8)
- Biochemical markers of time since death in cerebrospinal fluid: A first step towards “Forensomics” (2019) (8)
- Elevated plasma cysteinylglycine levels caused by cilastatin-associated antibiotic treatment (2005) (8)
- Involvement of the endogenous lectin CSL in adhesion of Chinese hamster ovary cells. (1991) (8)
- Variation of human salivary alpha-amylase proteoforms in three stimulation models (2019) (8)
- [CSF biomarkers: proteomics investigations and clinical applications in neurodegenerative disorders]. (2009) (8)
- Sub-acute intravenous exposure to Fe2O3 nanoparticles does not alter cognitive performances and catecholamine levels, but slightly disrupts plasma iron level and brain iron content in rats. (2018) (8)
- Editorial: Biomarkers of Alzheimer’s Disease: The Present and the Future (2016) (8)
- Cerebrospinal Fluid and Plasma Biomarkers do not Differ in the Presenile and Late-Onset Behavioral Variants of Frontotemporal Dementia. (2020) (7)
- An innovative biologic recycling process of leukoreduction filters to produce active human antimicrobial peptides (2014) (7)
- Role of an Endogenous Mannosyl-Lectin in Myelination and Stabilization of Myelin Structure (1990) (7)
- Neurite outgrowth of neurons of rat dorsal root ganglia induced by new neurotrophic substances with guanidine group (1993) (7)
- Identification of multiple proteoforms biomarkers on clinical samples by routine Top-Down approaches (2018) (7)
- Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aβ1–42 and Tau Proteins in Elderly Patients With Mild Cognitive Impairment (2018) (7)
- Quantifying RNA modifications by mass spectrometry: a novel source of biomarkers in oncology (2021) (7)
- Gravitational Transitions Increase Posterior Cerebral Perfusion and Systemic Oxidative-nitrosative Stress: Implications for Neurovascular Unit Integrity (2020) (7)
- Dental stem cells as a promising source for cell therapies in neurological diseases (2019) (7)
- Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF Biomarkers. (2018) (7)
- Regulatory context and validation of assays for clinical mass spectrometry proteomics (cMSP) methods (2018) (7)
- Cerebellar lectins. (1992) (7)
- MACVIA-LR (Fighting Chronic Diseases for Active and Healthy Ageing in Languedoc-Roussillon): A Success Story of the European Innovation Partnership on Active and Healthy Ageing. (2016) (6)
- [Alzheimer's disease cerebro-spinal fluid biomarkers: A clinical research tool sometimes useful in daily clinical practice of memory clinics for the diagnosis of complex cases]. (2017) (6)
- Ex Vivo Transmission of Mouse‐Adapted Prion Strains to N2a and GT1‐7 Cell Lines (2002) (6)
- From “Clinical Proteomics” to “Clinical Chemistry Proteomics”: considerations using quantitative mass-spectrometry as a model approach (2012) (6)
- Sampling Tube, a Critical Factor in Alzheimer’s Disease Biomarker Standardization (2010) (6)
- Sensitive protein misfolding cyclic amplification of sporadic Creutzfeldt–Jakob disease prions is strongly seed and substrate dependent (2021) (6)
- Hypoxemia increases blood-brain barrier permeability during extreme apnea in humans (2022) (6)
- Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study (2015) (6)
- [Presence of antibodies to lectin CSL in the blood of patients with multiple sclerosis patients]. (1990) (5)
- Prion Protein Expression and Processing in Human Mononuclear Cells: The Impact of the Codon 129 Prion Gene Polymorphism (2009) (5)
- Determination of plasma amino acids by fluorescent derivatization and reversed-phase liquid chromatographic separation. (2004) (5)
- The NeuroMET project: Metrology and innovation for early diagnosis and accurate stratification of patients with neurodegenerative diseases (2021) (5)
- The potential impact of salivary peptides in periodontitis (2021) (5)
- In Vivo Large Scale Mapping Of Protein Turnover In The Human Cerebrospinal Fluid (2019) (5)
- Tau protein in cerebrospinal fluid: a novel biomarker of the time of death? (2021) (5)
- Heat shock affects trafficking of DAX-1 by inducing its rapid and reversible cytoplasmic localization (2005) (5)
- Impact of biological matrix on inflammatory protein biomarker quantification based on targeted mass spectrometry. (2018) (5)
- HEPES inhibits the conversion of prion protein in cell culture. (2011) (5)
- Nano-flow vs standard-flow: Which is the more suitable LC/MS method for quantifying hepcidin-25 in human serum in routine clinical settings? (2018) (5)
- Generation of induced pluripotent stem cells (IRMBi001-A) from an Alzheimer's disease patient carrying a G217D mutation in the PSEN1 gene. (2019) (5)
- Comparison of cerebrospinal fluid tau, ptau(181), synuclein, and 14-3-3 for the detection of Creutzfeldt–Jakob disease in clinical practice (2022) (5)
- Serum glial fibrillary acidic protein is a predictor of brain metastases in patients with metastatic breast cancer (2021) (5)
- [Prions: where do we stand 20 years after the appearance of bovine spongiform encephalopathy?]. (2007) (4)
- Concussion history in rugby union players is associated with depressed cerebrovascular reactivity and cognition (2021) (4)
- Comparison between surface and bead-based MALDI profiling technologies using a single bioinformatics algorithm (2006) (4)
- Proteomic profile of cerebrospinal fluid in patients with multiple sclerosis using two dimensional gel electrophoresis (2016) (4)
- Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification (2020) (4)
- Brain Lectins:Structure and Function. (1992) (4)
- Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles (2022) (4)
- Quantitative mass spectrometry (SRM/MRM) for amyloid peptides, tau protein and apolipoprotein E in human cerebrospinal fluid for Alzheimer's disease diagnosis (2013) (4)
- NFL strongly correlates with TNF-R1 in the plasma of AD patients, but not with cognitive decline (2021) (4)
- Mass spectrometry follow-up of t181, s199, s202, t205, and T217 tau phosphorylation in cerebrospinal fluid from patients revealed a specific Alzheimer’s disease pattern (2015) (4)
- [Present possibilities and future development of clinical proteomics]. (2007) (4)
- From stem cells to prion signalling. (2002) (4)
- Comparison of Hydrophobic, Lipophilic and Immunodepletion Pre-Fractionation Methods for Label-Free LC-MS/MS Identification ofBiomarkers in Human Cerebrospinal Fluid (2014) (4)
- Cell-based therapy against prion diseases. (2019) (3)
- [Blood sampling using "dried blood spot": a clinical biology revolution underway?]. (2015) (3)
- Added value of hepcidin quantification for the diagnosis and follow-up of anemia-related diseases. (2017) (3)
- A Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging (2022) (3)
- Efficient extraction of intact HSA-Aβ peptide complexes from sera: Toward albuminome biomarker identification. (2020) (3)
- Chitinase 3-like 1 and Chitinase 3-like 2 as Diagnostic and Prognostic Biomarkers of Multiple Sclerosis (S53.005) (2014) (3)
- LONGITUDINAL CEREBROSPINAL FLUID BIOMARKER TRAJECTORIES ALONG THE ALZHEIMER'S DISEASE CONTINUUM: A MULTICENTRE EUROPEAN STUDY (2017) (3)
- Two dimensional gel electrophoresis analysis of mesenchymal stem cells. (2011) (3)
- Neurofilament Light Chain Levels Are Predictive of Clinical Conversion in Radiologically Isolated Syndrome (2022) (2)
- Interest of CSF markers in positive diagnosis of Alzheimer's disease in routine clinical practice (2009) (2)
- [Is Cerebellar Soluble Lectin a major immunological target in multiple sclerosis?]. (1991) (2)
- What is the potential of dried matrix spot sampling for cerebrospinal fluid analysis? (2015) (2)
- [Multiplexed analysis for identification and evaluation of novel biomarkers in biological fluids, tissue and cell extracts]. (2009) (2)
- Looking for new biomarkers of skin wound vitality with a cytokine-based multiplex assay: preliminary study. (2017) (2)
- PROFILING OF INTACT PROTEINS IN THE CSF OF ALZHEIMER’S DISEASE PATIENTS USING TOP DOWN CLINICAL PROTEOMICS (TDCP): A NEW APPROACH GIVING ACCESS TO ISOFORM SPECIFIC INFORMATION OF NEURODEGENERATIVE BIOMARKERS (2016) (2)
- Proteomics Challenges for the Assessment of Synuclein Proteoforms as Clinical Biomarkers in Parkinson’s Disease (2022) (2)
- Generation of induced pluripotent stem cells (iPSCs) IRMBi002-A from an Alzheimer's disease patient carrying a D694N mutation in the APP gene. (2019) (2)
- Proteomic Identification of Allergenic Proteins of Morus alba L. Pollenexacerbation. (2018) (2)
- [Injectable preparation of labeled leucine with the carbon 13 for a clinical research program on the Alzheimer disease: pharmaceutical control of raw materials and the finished product and stability study]. (2015) (2)
- Quiescin-sulfhydryl oxidase inhibits prion formation in vitro (2016) (2)
- Blood Biomarkers for Return to Play after Concussion in Professional Rugby Players. (2022) (2)
- Analytical challenges related to the use of biomarker ratios for the biological diagnosis of Alzheimer’s disease (2015) (2)
- ["Standard" protocol for evaluating the impact of preanalytical variables on peptidic and proteic analytes and standard coding of preanalytical procedures]. (2009) (1)
- Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function (2023) (1)
- MALDI‐TOF IP‐MS quantification of plasma amyloid peptides in Alzheimer’s disease (2020) (1)
- INNOVATIVE MEASUREMENTS FOR IMPROVED DIAGNOSIS AND MANAGEMENT OF NEURODEGENERATIVE DISEASES (2019) (1)
- Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity (2020) (1)
- Characterizing Deep White Matter Hyperintensities in Patients with Symptomatic Isolated Cortical Superficial Siderosis. (2017) (1)
- Sample PREanalytical Code Standard Preanalytical Coding for Biospecimens : Defining the (2010) (1)
- Predicting multiple sclerosis: a large international multicentre study (2015) (1)
- β-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer’s disease (2022) (1)
- A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles (2014) (1)
- [The information embedded into protein conformation: the mammalian prion protein is not the only one which "prionized"]. (2009) (1)
- Editorial: Proteomics as a Tool for Biomarker and Drug Target Discovery: Improving the Diagnosis and Treatment of Neurodegenerative Diseases (2020) (1)
- La Protéine du Prion (2002) (1)
- Endogenous mannose-binding lectins in brain development and function (1991) (1)
- Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals (2020) (1)
- Repeated neurofilament light chain measurements did not capture Riluzole therapeutic effect in amyotrophic lateral sclerosis patients (2022) (1)
- The EMPIR project : Innovative measurements for improved diagnosis and management of neurodegenerative diseases (NeuroMet) (2017) (1)
- From Chemical Drug to Immunotherapy: New Approaches for the Treatment of Prion Diseases (2003) (1)
- [CSF proteins: useful markers in Alzheimer's disease]. (2011) (1)
- International initiative for harmonization of cerebrospinal fluid diagnostic comments in Alzheimer's disease (2020) (1)
- [Cellular and scrapie prion proteins: which is the more toxic isoform?]. (2004) (1)
- Relationship between genome and epigenome - challenges and requirements for future research (2014) (1)
- 160 Mutant prion proteins acquire PrP5c-like properties in cultured cells: an experimental model of familial prion diseases (1996) (1)
- Efficient inhibition of infectious prions multiplication and release by targeting the exosomal pathway (2015) (1)
- P2-011 Transmissibility of prion diseases in a lemurian primate, Microcebus murinus (2006) (0)
- Capturing protein production and clearance in neurodegeneration with SILK (2019) (0)
- Transcriptomic and proteomic analyses of human endometrial receptivity under natural cycle (2012) (0)
- Intact Protein Analysis by LC-MS for Characterizing Biomarkers in Cerebrospinal Fluid. (2019) (0)
- Age Modifies the Association Between Apolipoprotein E Genotype and Alzheimer's Disease: A CSF Biomarker-Based Multicentric Case-Control Study (2019) (0)
- QUANTIFICATION OF HEPCIDIN-25 IN HUMAN CEREBROSPINAL FLUID: TECHNICAL FEASIBILITY AND BIOLOGICAL RELEVANCE IN NEURODEGENERATIVE DISEASES (2017) (0)
- Hepcidin: immunoanalytic characteristics. (2018) (0)
- Effects of iron oxide nanoparticles on SH-SY5Y neuroblastoma cell line (2016) (0)
- Applying a Proteoform profiling method for neurological disorder biomarker discovery (2017) (0)
- Amyloid imaging by 18F-florbetaben PET in a patient with isolated microbleeds and leukoencephalopathy (2015) (0)
- Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders (2020) (0)
- CSF AMYLOID-β 42/40 RATIO IN CLINICAL SETTINGS: A MULTICENTRIC STUDY (2014) (0)
- Plasma Aβ42/Aβ40 ratio is independent of renal function. (2023) (0)
- 75PREDICTION ACCURACY OF CLINICAL ASSESSMENT FOR CONVERSION TO ALZHEIMER’S DISEASE DEMENTIA IN SUBJECTS WITH SUBJECTIVE AND MILD COGNITIVE IMPAIRMENT: A LONGITUDINAL STUDY (2018) (0)
- Deciphering Black Extrinsic Tooth Stain Composition in Children Using Metaproteomics (2022) (0)
- Large scale proteomics exploration of human cerebrospinal fluid (CSF) in Alzheimer’s disease patients using stable isotope labeling amino acid in vivo (SILAV) (2015) (0)
- Diagnosis of Variant Creutzfeldt - Jakob Disease Using Protein Misfolding Cyclic Amplification (PMCA) (2018) (0)
- Ex vivo propagation of transmissible spongiform encephalopathies agents (2000) (0)
- The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases (2019) (0)
- [Scrapie, proteasome and endoplasmic reticulum]. (2003) (0)
- Neurofilaments: a key new biomarker for clinicians. Part 2: Neurofilaments, an asset beyond neurodegenerative diseases (2022) (0)
- gravitational Transitions Increase Blood-brain Barrier Permeability In Humans (2020) (0)
- Neurofilaments: a key new biomarker for clinicians. Part 1: Importance of neurofilaments in the management of neurodegenerative diseases (2022) (0)
- Familial Prion Diseases Modeled in Cell Culture (1998) (0)
- Increasing age and CSF biomarker levels in Alzheimer's disease: The PLM study (2013) (0)
- [SARS-CoV-2 and neurological disorders: the revelance of biomarkers?] (2021) (0)
- Lifelong exposure to high‐altitude hypoxia in humans is associated with improved redox homeostasis and structural–functional adaptations of the neurovascular unit (2023) (0)
- Profiling of intact proteins in the CSF of Alzheimer's disease patients using top down clinical proteomics: revealing specific isoform biomarker candidates (2016) (0)
- Quality Control Tools Human Biospecimen Research : Experimental Protocol and Updated (2009) (0)
- Recommendations to standardize Pre-analytical confounding factors in Alzheimer ’ s and Parkinson ’ s disease CSF biomarkers : an update (2015) (0)
- Equivalence between Innotest® and Lumipulse®G assays for CSF biomarker-based risk profiling in Alzheimer's disease: A multicenter study (2019) (0)
- Plasma biomarkers for the AT(N) classification and for the detection of Alzheimer’s disease (2021) (0)
- 1st Conference Clinical Trials on Alzheimer’s Disease September 17-18-19, 2008 School of Medecine Montpellier, France (2008) (0)
- INNOVATIVE THERAPEUTIC APPROACH COMBINING GENE AND CELL THERAPY IN A MOUSE MODEL OF PRION DISEASES (2014) (0)
- THE NATURAL HISTORY OF ALZHEIMER’S DISEASE IN DOWN SYNDROME (2019) (0)
- Analytical comparison of ELISA and mass spectrometry for quantification of serum hepcidin in critically ill patients. (2021) (0)
- CSF AD BIOMARKERS IN MEMORY CLINIC PATIENTS: THE EP.L.M.FR STUDY (2014) (0)
- Amyloid imaging by 18F-florbetaben PET in a patient with isolated microbleeds and leukoencephalopathy (2016) (0)
- Sensus Protocol That Specifically Links Cutoff Values to given Sam- Pling Tubes and Handling/analyti- Cal Protocols. Pierre Krolak-salmon Arnaud Coudreuse Diurnal Plasma Concentrations of Natriuretic Propeptides in Healthy Young Males (2012) (0)
- Investigation of the involvement of the prion protein in oxidative stress (2000) (0)
- Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease (2019) (0)
- The Aβ1–42/Aβ1–40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1–42 alone (2022) (0)
- Rapid and highly sensitive detection of variant Creutzfeldt - Jakob Disease prions binded on steel surfaces by PMCA: Application to Prion decontamination studies. (2017) (0)
- Development of a candidate reference measurement procedure by ID-LC-MS/MS for total tau protein measurement in cerebrospinal fluid (CSF) (2023) (0)
- Corrigendum: Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aß1−42, and Tau Proteins in Elderly Patients With Mild Cognitive Impairment (2019) (0)
- OF CSF AMYLOID BIOMARKERS TO DIFFERENTIATE FRONTOTEMPORAL DEMENTIA FROM ALZHEIMER DISEASE (2011) (0)
- A Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging (2022) (0)
- Wild-Type Mouse Prion Protein Neuroblastoma Cell Lines Overexpressing Mouse-Adapted Scrapie Strains to Murine Successful Transmission of Three (1999) (0)
- Transmissible Spongiform Encephalopathies or Prion Diseases - General Introduction (2004) (0)
- BETTER MEASUREMENT FOR IMPROVED DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE: UPDATE ON THE EMPIR NEUROMET PROJECT (2018) (0)
- Protein Structure and Biology (2013) (0)
- Association of biological sex with clinical outcomes and biomarkers of Alzheimer’s disease in adults with Down syndrome (2023) (0)
- A POTENTIAL REFERENCE MEASUREMENT PROCEDURE FOR QUANTIFICATION OF α-SYNUCLEIN IN CSF (2019) (0)
- The Stable Isotope Labeling Kinetics (SILK) road: turnover, synthesis and breakdown of proteins in vivo (2018) (0)
- The alternative proteome in neurobiology (2022) (0)
- Diagnosis of Variant Creutzfeldt - Jakob Disease in life Using Protein Misfolding Cyclic Amplification (PMCA). (2018) (0)
- Gene and cell therapy approaches for prion diseases (2011) (0)
- [The SFBC scientific workgroups]. (2013) (0)
- 105 Further analysis of a cell culture model of inherited prion diseases (1996) (0)
- A multimodal study on the effect of sex on Alzheimer's disease clinical and biomarker changes in adults with Down syndrome (2021) (0)
- COMBINING MATHEMATICAL MODEL AND CATECHOLAMINE QUANTIFICATIONS TO SCREEN ALZHEIMER DISEASE FROM A SIMPLE BLOOD TEST (2018) (0)
- PRESENILE- VS LATE-ONSET BEHAVIORAL FRONTO-TEMPORAL LOBAR DEGENERATION (BVFTLD): CLINICAL, RADIOLOGICAL, AND BIOLOGICAL COMPARISON (2016) (0)
- DETECTION AND QUANTIFICATION OF THE TAU PROTEIN AND ITS ISOFORMS IN THE CSF OF ALZHEIMER'S DISEASE PATIENTS USING MASS SPECTROMETRY (2014) (0)
- Development of a primary calibrator and candidate reference method for metrological traceability of tau protein results (2020) (0)
- Immunoassay and Mass Spectrometry Methods for Tau Protein Quantification in the Cerebrospinal Fluid (2021) (0)
- White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation (2018) (0)
- Interest of CSF p-Tau 181 and Amyloid-beta 1-38 for the diagnosis of frontotemporal dementia (2011) (0)
- CSF OREXIN-A/HYPOCRETIN-1 CHANGES IN THE ALZHEIMER DISEASE PROCESS (2016) (0)
- INTEREST IN CSF BIOMARKERS IN THE DIAGNOSIS OF LATE ONSET BV-FRONTOTEMPORAL LOBAR DEGENERATION (BV-FTLD) VERSUS ALZHEIMER'S DISEASE (AD) (2014) (0)
- [The reference site of the European Innovation Partnership on Active and Healthy Aging MACVIA-LR (the fight against chronic diseases for an active and healthy aging in Languedoc-Roussillon)]. (2015) (0)
- SEX DIFFERENCES IN CEREBROSPINAL FLUID NEUROFILAMENT LIGHT CHAIN LEVELS ARE CONSISTENT ACROSS COHORTS (2019) (0)
- [Dental stem cells: myth or hope in neuroregenerative medicine?] (2020) (0)
- Orexi: A the missing link in the amyloid process? (2015) (0)
- Hepcidin and ferritin levels in restless legs syndrome: a case–control study (2020) (0)
- Plasma phosphorylated tau 181 predicts amyloid status and conversion from mild cognitive impairment to dementia stage; major impact of renal function on diagnostic performance in the BALTAZAR cohort (2022) (0)
- New Perspectives of Multiplex Mass Spectrometry Blood Protein Quantification on Microsamples in Biological Monitoring of Elderly Patients (2023) (0)
- HIGHLY SPECIFIC CSF TAU HYPERPHOSPHORYLATION ON T217 OCCURS SIMULTANEOUSLY WITH AMYLOIDOSIS (2017) (0)
- A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease (2020) (0)
- Hypoxemia Destabilizes The Neurovascular Unit During Extreme Apnea In Humans (2022) (0)
- Variation of human salivary alpha-amylase proteoforms in three stimulation models (2019) (0)
- Serum neurofilament light chain cut-off definition for clinical diagnosis and prognosis of amyotrophic lateral sclerosis. (2023) (0)
- Comparison of ultrasensitive and mass spectrometry quantification of blood-based amyloid biomarkers for Alzheimer’s disease diagnosis in a memory clinic cohort (2023) (0)
- PERIPHERAL INFLAMMATORY PROCESSES IN ALZHEIMER DISEASE: BIOMARKERS PROFILING APPROACH (2014) (0)
- Beyond interest and limits of CSF biomarkers in clinical practice: The PLM study (2013) (0)
- Neurofilaments contribution in clinic: state of the art (2022) (0)
- Diagnosis of Methionine/Valine Variant Creutzfeldt - Jakob disease using PMCA in Cerebrospinal fluid (2018) (0)
- Reform of the outside nomenclature biomedical tests in France: a two year review. (2017) (0)
- Prion strains are differentially released through the exosomal pathway (2014) (0)
- Stable Isotope Labeling Kinetics in CNS Translational Medicine: Introduction to SILK Technology (2019) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Sylvain Lehmann?
Sylvain Lehmann is affiliated with the following schools:
